Zuzana Diamant (Former)
1 – 99 of 99
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
(
- Contribution to journal › Article
-
Mark
Metabolic pathways in immune senescence and inflammaging : Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
(
- Contribution to journal › Article
- 2023
-
Mark
Efficacy of FP-025 : A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma
(
- Contribution to journal › Letter
-
Mark
Allergen immunotherapy for allergic asthma : The future seems bright
(
- Contribution to journal › Article
-
Mark
Evaluating treatment response to mepolizumab in patients with severe CRSwNP*
(
- Contribution to journal › Article
-
Mark
Functional imaging for assessing regional lung ventilation in preclinical and clinical research
(
- Contribution to journal › Article
-
Mark
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma : An EAACI position paper
(
- Contribution to journal › Article
-
Mark
A EUFOREA comment on a lost comorbidity of asthma
(
- Contribution to journal › Letter
-
Mark
New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
(
- Contribution to journal › Scientific review
-
Mark
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
(
- Contribution to journal › Article
-
Mark
Biologics in severe asthma : A pragmatic approach for choosing the right treatment for the right patient
(
- Contribution to journal › Article
-
Mark
Integrating innovations in asthma research into clinical practice
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Eosinophils—from cradle to grave
(
- Contribution to journal › Article
-
Mark
Dysfunctional mucociliary clearance in asthma and airway remodeling – New insights into an old topic
(
- Contribution to journal › Article
-
Mark
EUFOREA pocket guide on the diagnosis and management of asthma : An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients
(
- Contribution to journal › Article
-
Mark
Asthma in the era of COVID-19
(
- Contribution to journal › Article
-
Mark
Pre-asthma : a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1—allergic asthma
(
- Contribution to journal › Scientific review
-
Mark
Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics
(
- Contribution to journal › Article
- 2022
-
Mark
The ICQ asthma algorithm : Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cysteinyl–leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics
(
- Contribution to journal › Letter
-
Mark
Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics
(
- Contribution to journal › Article
-
Mark
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses : EAACI task force on eicosanoids consensus report in times of COVID-19
(
- Contribution to journal › Article
-
Mark
Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP
(
- Contribution to journal › Article
-
Mark
Allergen provocation tests in respiratory research : building on 50 years of experience
(
- Contribution to journal › Article
-
Mark
An Algorithm for Strategic Continuation or Restriction of Asthma Medication Prior to Exercise Challenge Testing in Childhood Exercise Induced Bronchoconstriction
(
- Contribution to journal › Article
-
Mark
Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients
(
- Contribution to journal › Article
-
Mark
Physical exercise, immune response, and susceptibility to infections—current knowledge and growing research areas
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Vaccines and allergic reactions : The past, the current COVID-19 pandemic, and future perspectives
(
- Contribution to journal › Scientific review
-
Mark
Immune Profile in Patients With COVID-19 : Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome
(
- Contribution to journal › Article
-
Mark
Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
(
- Contribution to journal › Letter
-
Mark
Management of asthma in childhood : Study protocol of a systematic evidence update by the Paediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
-
Mark
Immune modulation via T regulatory cell enhancement : Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
(
- Contribution to journal › Article
-
Mark
First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025 : Results from Two Randomized Studies in Healthy Subjects
(
- Contribution to journal › Article
-
Mark
Allergen bronchoprovocation test : an important research tool supporting precision medicine
(
- Contribution to journal › Article
-
Mark
Editorial : Dealing with asthma during the turbulent times of coronavirus disease-2019
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Revisiting matrix metalloproteinase 12 : its role in pathophysiology of asthma and related pulmonary diseases
(
- Contribution to journal › Article
-
Mark
Asthma and severe acute respiratory syndrome coronavirus 2019 : current evidence and knowledge gaps
(
- Contribution to journal › Article
-
Mark
Use of fractional exhaled nitric oxide to guide the treatment of asthma an official american thoracic society clinical practice guideline
(
- Contribution to journal › Article
- 2020
-
Mark
Editorial : Asthma: a modifiable disease on a crossroad
(
- Contribution to journal › Article
-
Mark
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
(
- Contribution to journal › Scientific review
-
Mark
Letter to the editor : Indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: A randomized controlled cross-over study
(
- Contribution to journal › Article
-
Mark
Point-of-care biomarkers in asthma management : Time to move forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The need for clean air : The way air pollution and climate change affect allergic rhinitis and asthma
(
- Contribution to journal › Scientific review
-
Mark
Blood eosinophils : In quest of a Holy Grail for personalized asthma treatment with biologicals
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement
(
- Contribution to journal › Letter
-
Mark
Clinical and daily respiratory care and clinical trials within the COVID-19 era
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
COVID-19, chronic inflammatory respiratory diseases and eosinophils - Observationsfrom reported clinical case series
(
- Contribution to journal › Letter
-
Mark
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
(
- Contribution to journal › Article
-
Mark
Research Priorities in Pediatric Asthma : Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
-
Mark
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
(
- Contribution to journal › Scientific review
-
Mark
Real-life assessment of chronic rhinosinusitis patients using mobile technology : The mySinusitisCoach project by EUFOREA
(
- Contribution to journal › Article
-
Mark
Precision medicine and treatable traits in chronic airway diseases - where do we stand?
(
- Contribution to journal › Article
- 2019
-
Mark
Targeting lipid mediators in asthma : time for reappraisal
(
- Contribution to journal › Article
-
Mark
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases : An EAACI Taskforce on Immunopharmacology position paper
(
- Contribution to journal › Article
-
Mark
Much ado about Biologicals : Highlights of the Master Class on Biologicals, Prague, 2018
(
- Contribution to journal › Letter
-
Mark
Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices
(
- Contribution to journal › Article
-
Mark
EUFOREA consensus on biologics for CRSwNP with or without asthma
(
- Contribution to journal › Scientific review
-
Mark
Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases
(
- Contribution to journal › Article
-
Mark
The potential role of CD16highCD62Ldim neutrophils in the allergic asthma
(
- Contribution to journal › Letter
-
Mark
Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018
(
- Contribution to journal › Article
- 2018
-
Mark
Toward effective prescription of inhaled corticosteroids in chronic airway disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
ERS technical standard on bronchial challenge testing : pathophysiology and methodology of indirect airway challenge testing
(
- Contribution to journal › Article
-
Mark
Personalized Approach to Severe Asthma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Towards precision medicine in severe asthma : Treatment algorithms based on treatable traits
(
- Contribution to journal › Scientific review
-
Mark
Emerging roles of innate lymphoid cells in inflammatory diseases : Clinical implications
(
- Contribution to journal › Scientific review
-
Mark
Targeting the interleukin-4 and interleukin-13 pathways in severe asthma : Current knowledge and future needs
(
- Contribution to journal › Scientific review
-
Mark
The road to precision medicine in asthma : Challenges and opportunities
(
- Contribution to journal › Article
-
Mark
Assessing patient-reported outcomes in asthma and COPD patients : Which can be recommended in clinical practice?
(
- Contribution to journal › Scientific review
-
Mark
Club cell protein (CC16) in plasma, bronchial brushes, BAL and urine following an inhaled allergen challenge in allergic asthmatics
(
- Contribution to journal › Article
-
Mark
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations : A randomized controlled study
(
- Contribution to journal › Article
- 2017
-
Mark
Allergy in severe asthma
(
- Contribution to journal › Article
-
Mark
Generic medications in precision medicine in asthma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Role of biologics targeting type 2 airway inflammation in asthma : What have we learned so far?
(
- Contribution to journal › Scientific review
-
Mark
ERS technical standard on bronchial challenge testing : General considerations and performance of methacholine challenge tests
(
- Contribution to journal › Article
-
Mark
Small airway involvement in the late allergic response in asthma
(
- Contribution to journal › Article
- 2016
-
Mark
Effects of low-versus high-dose fluticasone propionate/formoterol fumarate combination therapy on AMP challenge in asthmatic patients: A double-blind, randomised clinical trial.
(
- Contribution to journal › Article
-
Mark
A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study.
(
- Contribution to journal › Article
-
Mark
Editorial: The new look on asthma: linking phenotypes, endotypes and biomarkers to asthma management.
(
- Contribution to journal › Letter
-
Mark
Role of T2 inflammation biomarkers in severe asthma.
(
- Contribution to journal › Scientific review
-
Mark
Revisiting the role of the mast cell in asthma.
(
- Contribution to journal › Scientific review
-
Mark
A randomized, 5-arm dose finding study with a mite allergoϊd SCIT in allergic rhinoconjunctivitis patients.
2016) In Allergy(
- Contribution to journal › Article
- 2015
-
Mark
Obesity and asthma: current knowledge and future needs
(
- Contribution to journal › Scientific review
-
Mark
Antifungals in severe asthma
(
- Contribution to journal › Scientific review
-
Mark
Reproducibility of biomarkers in induced sputum and in serum from chronic smokers.
(
- Contribution to journal › Article
-
Mark
Guidance for the regulatory status of allergen extracts in clinical trials.
(
- Contribution to journal › Letter
-
Mark
Can a single dose response predict the effect of montelukast on exercise-induced bronchoconstriction?
2015) In Pediatric Pulmonology(
- Contribution to journal › Article
-
Mark
Kinetics of TH2 biomarkers in sputum of asthmatics following inhaled allergen.
(
- Contribution to journal › Article
-
Mark
Application of nitric oxide measurements in clinical conditions beyond asthma.
(
- Contribution to journal › Article
- 2014
-
Mark
Disease models of chronic inflammatory airway disease: applications and requirements for clinical trials.
(
- Contribution to journal › Scientific review
-
Mark
Current evidence and future research needs for FeNO measurement in respiratory diseases.
(
- Contribution to journal › Scientific review
-
Mark
The use of health status questionnaires in the management of chronic obstructive pulmonary disease patients in clinical practice
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
(
- Contribution to journal › Article
-
Mark
Which Biomarkers Are Effective for Identifying Th2-Driven Inflammation in Asthma?
(
- Contribution to journal › Scientific review
-
Mark
The 5-lipoxygenase-activating protein inhibitor, GSK2190915, attenuates the early and late responses to inhaled allergen in mild asthma
(
- Contribution to journal › Article
-
Mark
Inhaled allergen bronchoprovocation tests.
(
- Contribution to journal › Article
-
Mark
Launching the BIOSPIT initiative: Harmonizing sputum outcomes in multicenter trials
(
- Contribution to journal › Letter
-
Mark
Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: A survey
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
(
- Contribution to journal › Article
- 2012
-
Mark
Clinical aspects of using exhaled NO in asthma diagnosis and management
(
- Contribution to journal › Scientific review